{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:50:51Z","timestamp":1791093051482,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T00:00:00Z","timestamp":1358380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054499","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T22:09:50Z","timestamp":1358460590000},"page":"e54499","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":74,"title":["Transforming Growth Factor \u03b2 Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats"],"prefix":"10.1371","volume":"8","author":[{"given":"Hong","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lonning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Arbeeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"JJ Jiao","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"R Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ncpgasthep0813","article-title":"Reversibility of Hepatic Fibrosis and Cirrhosis - Is it all Hype?","volume":"4","author":"SL Friedman","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"ref5","unstructured":"Tangkijvanich P, Yee HF (2002) Cirrhosis - can we reverse hepatic fibrosis? Eur J Surg Suppl 587: 100\u201312."},{"key":"ref6","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"D Povero","year":"2010","journal-title":"Histol Histopathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets","volume":"10","author":"AM Gressner","year":"2006","journal-title":"J Cellular and Molecular Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1440-1746.2008.05345.x","article-title":"Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?","volume":"23","author":"OA Gressner","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-\u03b2 signaling pathway in hepatic fibrosis","volume":"26","author":"X Liu","year":"2006","journal-title":"Liver Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/jpet.105.095042","article-title":"Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis","volume":"316","author":"I Bergheim","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1111\/j.1440-1746.2007.05285.x","article-title":"New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury","volume":"23","author":"GE Arteel","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/emm.2001.31","article-title":"Chronic liver injury, TGF-beta, and cancer","volume":"33","author":"Bissell DM","year":"2001","journal-title":"Exp Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.18388\/abp.2005_3446","article-title":"TGF beta signaling and its role in tumour pathogenesis","volume":"52","author":"B Kaminska","year":"2005","journal-title":"Acta Biochimica Polonica"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng1001-117","article-title":"TGF-beta signaling in tumor suppression and cancer progression","volume":"29","author":"R Derynck","year":"2001","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00535-006-1795-0","article-title":"Transforming growth factor-\u03b2 during carcinogenesis: the shift from epithelial to mesenchymal signaling","volume":"41","author":"K Matsuzaki","year":"2006","journal-title":"J Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jgm.1303","article-title":"Adenoviral delivery of dominant-negative transforming growth factor \u03b2 type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats","volume":"11","author":"AM Marquez-Aguirre","year":"2009","journal-title":"The Journal of Gene Medicine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32673","article-title":"Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-\u03b2 soluble receptor: implications for antifibrotic therapy","volume":"35","author":"Y Yata","year":"2002","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1073\/pnas.96.22.12719","article-title":"In vivo inhibition of rat stellate cell activation by soluble transforming growth factor \u03b2 type II receptor: a potential new therapy for hepatic fibrosis","volume":"96","author":"J George","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref19","first-page":"300","article-title":"Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by concanavalin A in mice","volume":"8","author":"W Xu","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1007082515548","article-title":"Cholangiocarcinoma and liver cirrhosis in relation to changes due to thioacetamide","volume":"208","author":"A Al-Bader","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"ref21","first-page":"631","article-title":"Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma","volume":"25","author":"CN Yeh","year":"2004","journal-title":"Carcinogenesis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(98)80318-8","article-title":"Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers","volume":"28","author":"C Pilette","year":"1998","journal-title":"J Hepatol"},{"key":"ref23","first-page":"9","article-title":"The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas","volume":"15","author":"C Stroescu","year":"2006","journal-title":"J Gastrointest Liver Dis"},{"key":"ref24","first-page":"9","article-title":"A novel chronic cirrhosis TAA-induced model in rats","volume":"3","author":"RR Guerra","year":"2010","journal-title":"Braz J Vet Pathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF- family signaling","volume":"425","author":"R Derynck","year":"2003","journal-title":"Nature"},{"key":"ref26","first-page":"56","article-title":"Experimental models of hepatic fibrosis: Semin Liver Dis","volume":"10","author":"H Tsukamoto","year":"1990"},{"key":"ref27","first-page":"886","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology","volume":"52","author":"TT Chang","year":"2010"},{"key":"ref28","first-page":"498","article-title":"Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy","volume":"33","author":"F P\u00e9rez Rold\u00e1n","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1478-3231.2009.02155.x","article-title":"Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells","volume":"30","author":"A Mart\u00ednez-Rizo","year":"2010","journal-title":"Liver Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2009.02.025","article-title":"Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats","volume":"51","author":"PF Hu","year":"2009","journal-title":"J Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.20903","article-title":"Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice","volume":"42","author":"H Wang","year":"2005","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.febslet.2007.05.049","article-title":"PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA","volume":"581","author":"H Wang","year":"2007","journal-title":"FEBS Letters"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"NA Bhowmick","year":"2004","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1038\/onc.2010.236","article-title":"The role of signaling pathways in the development and treatment of hepatocellular carcinoma","volume":"9","author":"S Whittaker","year":"2010","journal-title":"Oncogene"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1158\/0008-5472.CAN-05-4609","article-title":"Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice","volume":"66","author":"PA Farazi","year":"2006","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T16:36:21Z","timestamp":1595262981000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054499"}},"subtitle":[],"editor":[{"given":"Johannes","family":"Haybaeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054499","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,17]]}}}